This is a community-generated profile. If you work at Aryx Therapeutics, to claim it.
Aryx Therapeutics Funding
$28.3M
33 rounds
Aryx Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds, totaling in an amount of $28.3M. Their most recent funding was raised on August 16, 2010.
Investors of Aryx Therapeutics
Scottish Widows Investment Partnership
OrbiMed
ATEL Ventures
Itochu Technology Ventures
Tokyo based, early stage investor
Montreux Equity Partners
Merlin Biomed
Nomura Phase4 Ventures
Chief Evangelist at Good.co, Former: Managing Partner at LAUNCH, 15+ years in Biotech/Pharma, Professor at Purdue University, Native American, Angel Investor
Lighthouse Capital Partners
Rounds
S
